ANZELLA HINSON: Open Payments
NPI 1760106363 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 22 payments from 13 companies in 2025. Trend: 2023 $436 · 2024 $173 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 3 | $74 |
| Fennec Pharmaceuticals, Inc. | 3 | $71 |
| Daiichi Sankyo Inc. | 3 | $70 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: CABOMETYX, Fyarro, KEYTRUDA, DATROWAY, SCEMBLIX, ORGOVYX, ZEPZELCA, Vyloy.
Industry payments across GA — which companies pay providers there.
